BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 14, 2026; 32(42): 121556
Published online Nov 14, 2026. doi: 10.3748/wjg.121556
Table 9 Comparison of clinical outcomes between low and normal groups under Kyle criteria, n (%)
Characteristics
12 weeks clinical outcomes
54 weeks clinical outcomes
Low PhA (n = 42)
Normal PhA (n = 80)
P value
Low PhA (n = 35)
Normal PhA (n = 53)
P value
Medication therapeutic escalation/switching21 (50.00)14 (17.50)< 0.001a24 (68.57)13 (24.53)< 0.001a
Readmission27 (64.29)12 (15.00)< 0.001a28 (80.00)24 (45.28)0.001a
Surgical intervention4 (9.52)1 (1.25)0.047a7 (20.00)1 (1.89)0.006a


Write to the Help Desk